Brain Tumors: From Molecular Basis to Therapy: 2nd Edition
A Special Issue of Brain Sciences (ISSN 2076-3425) belonging to the section "Neuro-oncology".
Deadline for manuscript submissions: 31 January 2027 | Viewed by 803
Editor
Interests: neuro-oncology; radiotherapy in CNS cancers; radiosurgery; bio-molecular prognostic factors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The landscape of brain tumor research is rapidly evolving, driven by the urgent need to improve diagnosis, treatment and patient outcomes. Brain tumors, ranging from benign to highly malignant forms, present significant clinical challenges due to their complex biology and the critical nature of their location. Despite considerable advances in medical research, many aspects of brain tumor pathology, genetics and therapeutic response remain incompletely understood.
This Second Edition of the Special Issue aims to build upon the progress and insights generated by the previous volume, further addressing existing gaps by promoting a deeper understanding of the molecular underpinnings of brain tumors and translating these insights into innovative therapeutic strategies. By tackling key challenges such as tumor heterogeneity, resistance to conventional therapies and the limiting effects of the blood–brain barrier on drug delivery, we seek to foster breakthroughs that can ultimately transform patient care.
To advance knowledge and support the development of more effective treatments, this Special Issue will encompass a broad range of topics, including but not limited to:
- Molecular and Genetic Basis of Brain Tumors: Investigations into genetic alterations, signaling pathways and molecular mechanisms driving tumor initiation and progression.
- Innovative Diagnostic Techniques: Development and validation of novel biomarkers, imaging technologies and diagnostic tools aimed at improving early detection and accurate classification of brain tumors.
- Therapeutic Advances: Exploration of cutting-edge treatments, including targeted therapies, immunotherapies and personalized medicine approaches tailored to individual tumor profiles.
- Overcoming Therapeutic Resistance: Studies addressing mechanisms underlying resistance to current therapies and proposing strategies to overcome these barriers.
- Drug Delivery Systems: Innovations designed to enhance the delivery of therapeutic agents across the blood–brain barrier, improving both efficacy and safety.
- Clinical Trials and Translational Research: Reports on clinical trials, case studies and translational research bridging laboratory discoveries and clinical application.
We invite researchers, clinicians and scholars worldwide to contribute original research articles, review papers and case studies to this Special Issue. Your expertise and insights are essential for advancing our understanding of brain tumors and developing more effective therapies. By participating in this Special Issue, you will join a collaborative effort aimed at addressing some of the most pressing challenges in brain tumor research and treatment.
Dr. Paolo Tini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumors
- molecular pathways
- targeted therapy
- diagnostic biomarkers
- predictive biomarkers
- therapeutic resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Brain Tumors: From Molecular Basis to Therapy in Brain Sciences (8 articles)
